State ID
Clinical Trials in Idaho
Recruiting clinical trials with at least one study location in Idaho. Data updated daily from ClinicalTrials.gov.
Top Conditions in Idaho
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT05998005 N/A
Recruiting
First Face Training Evaluation in Tribal Communities
Condition
Mental Health
Enrollment
1,000 pts
Location
United States
Sponsor
Cambridge Health Alliance
NCT06999603 Phase 2
Recruiting
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respira...
Condition
Viral Pneumonia
Enrollment
550 pts
Location
United States, Belgium, France
Sponsor
Synairgen Research Ltd.
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT05977751 N/A
Recruiting
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
Condition
Contraception
Enrollment
573 pts
Location
United States
Sponsor
Femasys Inc.
NCT06972459 Phase 3
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight a...
Condition
Obesity
Enrollment
600 pts
Location
United States, Argentina, China
Sponsor
Eli Lilly and Company
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT06679140 Phase 3
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolesc...
Condition
COVID-19 SARS-CoV-2 Infection
Enrollment
2,330 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT07280065 Phase 3
Recruiting
REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
Condition
PTSD - Post Traumatic Stress Disorder
Enrollment
1,900 pts
Location
United States, Australia
Sponsor
Senseye, Inc.
NCT05677451 Phase 3
Recruiting
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, ...
Condition
Chronic Spontaneous Urticaria
Enrollment
100 pts
Location
United States, Argentina, Canada
Sponsor
Novartis Pharmaceuticals
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT05354141 Phase 3
Recruiting
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (...
Condition
Acute Respiratory Distress Syndrome
Enrollment
970 pts
Location
United States
Sponsor
Direct Biologics, LLC
NCT06719141 Phase 3
Recruiting
A Study to Investigate LP352 in Children and Adults With Developmental and Epile...
Condition
Developmental and Epileptic Encephalopathy
Enrollment
320 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
NCT07283939 N/A
Recruiting
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned...
Condition
Ampulla of Vater Carcinoma
Enrollment
420 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
NCT06866405 Phase 3
Recruiting
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vac...
Condition
RSV Infection
Enrollment
550 pts
Location
United States, Argentina, South Africa
Sponsor
Pfizer
NCT06679985 Phase 2
Recruiting
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Part...
Condition
Hepatocellular Carcinoma
Enrollment
72 pts
Location
United States, Australia, Canada
Sponsor
Coherus Oncology, Inc.
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06389136 Phase 3
Recruiting
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Der...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Canada, Colombia
Sponsor
AbbVie
Page 1 of 3 — 52 trials total